To explore whether saturable Hsp90 expression is affected in neurodegenerative brain disorders, saturation binding assays were explored on AD brain tissue and revealed reduced Bmax compared with that of age-matched controls. The gene discussed is HSP90AA1; the disease is Alzheimer disease.